Aptevo Therapeutics Inc. Amortization of Intangible Assets
Aptevo Therapeutics Inc. (APVO) reported Amortization of Intangible Assets of $800.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2020-03-25
- Aptevo Therapeutics Inc. amortization of intangible assets for fiscal 2019 was $800.00K, a 0.00% change from fiscal 2018.
- Aptevo Therapeutics Inc. amortization of intangible assets for fiscal 2018 was $800.00K, a 0.00% change from fiscal 2017.
- Aptevo Therapeutics Inc. amortization of intangible assets for fiscal 2017 was $800.00K, a 0.00% change from fiscal 2016.
- Aptevo Therapeutics Inc. amortization of intangible assets for fiscal 2016 was $800.00K, a 76.47% decline from fiscal 2015.
| Period end | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|
| 2019-12-31 | $800.00K 10-K · filed 2020-03-25 | ||
| 2018-12-31 | $800.00K 10-K · filed 2019-03-18 | ||
| 2017-12-31 | $800.00K 10-K · filed 2019-03-18 | ||
| 2016-12-31 | $800.00K 10-K · filed 2018-03-13 | $2.20M 10-K · filed 2017-03-31 | |
| 2016-06-30 | $1.17M 10-Q/A · filed 2016-09-22 | ||
| 2015-12-31 | $3.40M 10-K · filed 2017-03-31 | ||
| 2015-06-30 | $896.00K 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |